Status:

COMPLETED

Anterior Resection Syndrome Following Sphincter-preserving Surgery

Lead Sponsor:

Queen Mary University of London

Collaborating Sponsors:

The Royal College of Surgeons of England

Conditions:

Rectal Cancer

Eligibility:

All Genders

18+ years

Brief Summary

Bowel cancer is the third most common cancer in the UK in both males and females. The rectum is the most commonly affected part of the bowel. Improvements in surgery have meant that many patients with...

Detailed Description

One of the main aims when carrying out surgery for rectal cancer is to avoid patients ending up with a permanent stoma. The current standard operation for resection of the rectum is an anterior resect...

Eligibility Criteria

Inclusion

  • Patients having had an anterior resection for rectal cancer who are more than 12 months post surgery
  • Patients who are more than 12 months post reversal of any defunctioning stoma
  • Aged over 18 years

Exclusion

  • Any inclusion criteria not met
  • Presence of a stoma
  • Local recurrence of cancer
  • Current adjuvant therapy
  • Further rectal surgery after the initial operation
  • Insufficient written English to participate

Key Trial Info

Start Date :

May 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2015

Estimated Enrollment :

1197 Patients enrolled

Trial Details

Trial ID

NCT02190656

Start Date

May 1 2014

End Date

September 1 2015

Last Update

April 5 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Queen Mary University of London

London, United Kingdom, E1 2AT